-
-
-
-
-
-
-
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised to $37 at UBS
-
-
-
-
-
-
-
Teva Pharmaceutical's branded drugs boost first quarter profit
-
-
-
-
-
-
-
Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
-
-
-
-
-
-
-
Alvotech (ALVO) and Teva (TEVA) Announce US Approval of SIMLANDI
-
-
-
-
-
-
-
Teva Pharma (TEVA) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY23 Guidance
-
-
-
-
-
-
-
Teva Pharma (TEVA) Tops Q2 EPS by 3c, Offers Guidance
-
1,227,475 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

